Quince Therapeutics Inc

Biotech Stocks Healthcare Stocks

$18.19

-0.22 (-1.21%)

As of Jun 30, 10:55 PM ET ·

Analyst Consensus

Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 5 63%

Sell 3 38%

Price Target

Analyst Price Target +120.7% upside

Low Target $31.69

Average Target $40.14

High Target $63.06

Current Price $18.19

Current
$18.19

Target
$40.14

$31.69 $40.14 avg $63.06

Scenario Analysis

Bear Case

$31.69

74.2%

Low target

Base Case

$40.14

+120.7%

Avg target

Bull Case

$63.06

+246.7%

High target

Risk/Reward

3.3x

Highly favorable

Price in Context

52-Week High

$45.50

-60.0% from high

52-Week Low

$0.79

+2,202.5% from low

Target vs 52W High

$40.14

-11.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%